The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

New recommendations from the National Academies of Sciences, Engineering, and Medicine are asking scientists to dive into ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

From the anti-vaccine movement and COVID denialism to the promotion of raw pet food, the wellness-industrial complex has ...

In a statement today, the company said it supports recent precautionary measures and that thorough investigations are needed ...

Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...

The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...

Following immunotherapy treatments in the last decade, new therapeutic strategies for cancer are beginning to emerge.

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...